|
EXPLORING THE FUNCTION OF THE LONG NON-CODING TRANSCRIPTOME IN HUMAN CHROMATIN REPLICATION
HUMAN CHROMATIN
|
PRE2018-085992
|
MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
|
Foundation for Applied Medical research
|
2018 - MINECO FPI
|
18-06-2019
|
88.250,00€
|
ERDF funds
|
|
MINECO STABILIZATION place RYC-2012-10699
|
RYC-2012-10699
|
MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
|
Foundation for Applied Medical research
|
2012 - MINECO RAMON Y CAJAL
|
01-06-2019
|
100.000,00€
|
-
|
|
NANOENCAPSULATED METABOLITES AS A SOLUTION TO LEAVE EFFICACY OF NATURAL BIOACTIVE COMPOUNDS ON OBESITY AND ASSOCIATED COMORBIDITIES
|
0011-1383-2019-000005 PC066
|
GOVERNMENT OF NAVARRA
|
University of Navarra
|
2019 GN Centers
|
22-05-2019
|
76.181,71€
|
-
|
|
development from Structures 3D for tissue engineering
|
0011-1383-2019-000005 PC074
|
GOVERNMENT OF NAVARRA
|
University of Navarra
|
2019 GN Centers
|
22-05-2019
|
45.552,13€
|
-
|
|
New generation of superparamagnetic particle-assisted cancer theranostic platforms
|
0011-1383-2019-000005 PC072
|
GOVERNMENT OF NAVARRA
|
University of Navarra
|
2019 GN Centers
|
17-05-2019
|
113.465,43€
|
-
|
|
Immunotherapy strategies based on redirected T lymphocytes.
|
0011-1383-2019-000006
|
GOVERNMENT OF NAVARRA
|
Foundation for Applied Medical research
|
2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH BODIES
|
17-05-2019
|
102.651,25€
|
-
|
|
Study of the p27-Cdk2 axis as a new therapeutic target for combating obesity and Alzheimer's disease during aging
|
0011-1383-2019-000006
|
GOVERNMENT OF NAVARRA
|
Foundation for Applied Medical research
|
2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH BODIES
|
17-05-2019
|
21.808,75€
|
-
|
|
Identification of specific neuroinflammation patterns in alpha-synuclein-dependent neuronal death in models of Parkinson's disease.
|
0011-1383-2019-000006
|
GOBIERNO DE NAVARRA
|
Foundation for Applied Medical research
|
2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH BODIES
|
17-05-2019
|
100.795,00€
|
-
|
|
Gene therapy for congenital metabolic diseases with neurological involvement: cerebrotendinous xanthomatosis.
|
0011-1383-2019-000006
|
GOVERNMENT OF NAVARRA
|
Foundation for Applied Medical research
|
2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH BODIES
|
17-05-2019
|
116.861,88€
|
-
|
|
Platform for capturing vital signs in non-clinical environments.
|
0011-1383-2019-000006
|
GOVERNMENT OF NAVARRA
|
Foundation for Applied Medical research
|
2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH BODIES
|
17-05-2019
|
52.862,01€
|
-
|
|
|
|
|
|
|
|
|